Overview

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The chief purpose of this research is to evaluate interferon alpha sensitivity and cell type specific levels of interferon receptor and interferon stimulated genes and proteins in HIV/ HCV (hepatitis C virus) coinfected persons before and after administration of HIV medications (antiretroviral therapy).
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Anti-Retroviral Agents
Emtricitabine
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Interferon-alpha
Interferons
Raltegravir Potassium
Tenofovir